344 related articles for article (PubMed ID: 15006706)
41. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
[TBL] [Abstract][Full Text] [Related]
42. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease.
Scherer SS; Bone LJ; Deschênes SM; Abel A; Balice-Gordon RJ; Fischbeck KH
Novartis Found Symp; 1999; 219():175-85; discussion 185-7. PubMed ID: 10207904
[TBL] [Abstract][Full Text] [Related]
43. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
[TBL] [Abstract][Full Text] [Related]
44. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy.
Ionasescu V; Ionasescu R; Searby C
Am J Med Genet; 1996 Jun; 63(3):486-91. PubMed ID: 8737658
[TBL] [Abstract][Full Text] [Related]
45. Central motor and sensory pathway involvement in an X-linked Charcot-Marie-Tooth family.
Zambelis T; Panas M; Kokotis P; Karadima G; Kararizou E; Karandreas N
Acta Neurol Belg; 2008 Jun; 108(2):44-7. PubMed ID: 18795595
[TBL] [Abstract][Full Text] [Related]
46. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins.
VanSlyke JK; Deschenes SM; Musil LS
Mol Biol Cell; 2000 Jun; 11(6):1933-46. PubMed ID: 10848620
[TBL] [Abstract][Full Text] [Related]
47. X-linked Charcot-Marie-Tooth disease caused by a novel point mutation in the connexin-32 gene.
Ma W; Farrukh Nizam M; Grewal RP
Neurol Sci; 2002 Oct; 23(4):195-7. PubMed ID: 12536289
[TBL] [Abstract][Full Text] [Related]
48. Schwann Cell and the Pathogenesis of Charcot-Marie-Tooth Disease.
Murakami T; Sunada Y
Adv Exp Med Biol; 2019; 1190():301-321. PubMed ID: 31760652
[TBL] [Abstract][Full Text] [Related]
49. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease.
Paulson HL; Garbern JY; Hoban TF; Krajewski KM; Lewis RA; Fischbeck KH; Grossman RI; Lenkinski R; Kamholz JA; Shy ME
Ann Neurol; 2002 Oct; 52(4):429-34. PubMed ID: 12325071
[TBL] [Abstract][Full Text] [Related]
50. Persistent CNS dysfunction in a boy with CMT1X.
Siskind C; Feely SM; Bernes S; Shy ME; Garbern JY
J Neurol Sci; 2009 Apr; 279(1-2):109-13. PubMed ID: 19193385
[TBL] [Abstract][Full Text] [Related]
51. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
[TBL] [Abstract][Full Text] [Related]
52. X-linked Charcot Marie Tooth mutations alter CO
Butler J; Dale N
Front Cell Neurosci; 2023; 17():1330983. PubMed ID: 38188670
[TBL] [Abstract][Full Text] [Related]
53. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
54. Functional analysis of connexin-26 mutants associated with hereditary recessive deafness.
Wang HL; Chang WT; Li AH; Yeh TH; Wu CY; Chen MS; Huang PC
J Neurochem; 2003 Feb; 84(4):735-42. PubMed ID: 12562518
[TBL] [Abstract][Full Text] [Related]
55. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease.
Dubourg O; Tardieu S; Birouk N; Gouider R; Léger JM; Maisonobe T; Brice A; Bouche P; LeGuern E
Brain; 2001 Oct; 124(Pt 10):1958-67. PubMed ID: 11571214
[TBL] [Abstract][Full Text] [Related]
56. New mutation of gap junction protein beta1 (GJB1) gene in X-linked hereditary motor and sensory neuropathy.
Umehara F; Arimura Y; Osame M; Minato S; Nakahara K
J Peripher Nerv Syst; 2006 Mar; 11(1):96-7. PubMed ID: 16519791
[No Abstract] [Full Text] [Related]
57. The cataract-inducing S50P mutation in Cx50 dominantly alters the channel gating of wild-type lens connexins.
DeRosa AM; Xia CH; Gong X; White TW
J Cell Sci; 2007 Dec; 120(Pt 23):4107-16. PubMed ID: 18003700
[TBL] [Abstract][Full Text] [Related]
58. Role of connexin 32 hemichannels in the release of ATP from peripheral nerves.
Nualart-Marti A; del Molino EM; Grandes X; Bahima L; Martin-Satué M; Puchal R; Fasciani I; González-Nieto D; Ziganshin B; Llobet A; Barrio LC; Solsona C
Glia; 2013 Dec; 61(12):1976-89. PubMed ID: 24123415
[TBL] [Abstract][Full Text] [Related]
59. Mutation analysis of the connexin 32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations.
Nelis E; Simokovic S; Timmerman V; Löfgren A; Backhovens H; De Jonghe P; Martin JJ; Van Broeckhoven C
Hum Mutat; 1997; 9(1):47-52. PubMed ID: 8990008
[No Abstract] [Full Text] [Related]
60. Mutations of connexin 26 at position 75 and dominant deafness: essential role of arginine for the generation of functional gap-junctional channels.
Deng Y; Chen Y; Reuss L; Altenberg GA
Hear Res; 2006 Oct; 220(1-2):87-94. PubMed ID: 16945493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
